Clinical Trials Browser

Withdrawn × Precursor Cell Lymphoblastic Leukemia-Lymphoma × blinatumomab × Clear all

NCT03982992 2024-03-12

DLI-TARGET

Phase 2 Withdrawn

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03628053 2020-07-09

OBERON

Phase 3 Withdrawn

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma